TESSA JANOVSKY: Open Payments
NPI 1538680079 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,668 in 62 payments from 9 companies in 2025. Trend: 2023 $1,488 · 2024 $3,126 · 2025 $2,668
Food & beverage: $1,678Consulting: $940Travel & lodging: $50
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 25 | $1,558 |
| Madrigal Pharmaceuticals | 17 | $682 |
| ABBVIE INC. | 5 | $111 |
| Ipsen Biopharmaceuticals, Inc | 4 | $93 |
| Intercept Pharmaceuticals, Inc. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Mirum Pharmaceuticals, Inc. | 2 | $34 |
| Eton Pharmaceuticals, Inc. | 1 | $20 |
Products named: Livdelzi, REZDIFFRA, MAVYRET, IQIRVO, OCALIVA, XIFAXAN, Livmarli, GALZIN.
Industry payments across AZ — which companies pay providers there.
